SETIA ALAM, April 7 (Bernama) — The ImmuSAFE COVID+ biochip test will be used as one of the tests to verify the efficacy of the various vaccines used in Malaysia, in line with its goal to achieve herd immunity from COVID-19 under the National COVID-19 Immunisation Plan.
The Ministry of Health (MOH) announced today that the immune response tests related with COVID-19 vaccines will be done using the ImmuSAFE biochip technology, jointly developed between Malaysia Automotive, Robotics and IoT Institute (MARii), Sengenics and the Institute for Medical Research (IMR).
